Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Soochow University)

Nature Communications

September 16, 2019

10.1038/s41467-019-12032-9

Cited by 34

Related Papers

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2013|246

Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression

|PLoS ONE|2013|92

A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

|Journal of Hematology & Oncology|2020|50

EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN

|Oncotarget|2017|42

<p>Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-&gamma;-associated JAK-STAT pathway</p>

|OncoTargets and Therapy|2019|31